The effect of two Sicilian red wines on some cardiovascular risk factors;Effetto di due vini rossi Siciliani su alcuni fattori di rischio cardiovascolare

Italian Heart Journal, Supplementi

Volumn 5, Issue 5, 2004, Pages 382-388

  Avellone, Gino ^a   Di Garbo, Vincenzo ^a   Campisi, Domenico ^a   Alonzo, Giuseppe ^a   Gambino, Leonardo ^b   Avellone, Giuseppe ^a   De Simone, Rosa ^a   Raneli, Gilia ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Laboratorio Agroalimentare ed Ambientale   (Italy)

Author keywords

Antioxidants; Diet; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; ITALY; MALE; MIDDLE AGED; RISK FACTOR; WINE;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS; WINE;

EID: 6044270372     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Avellone G, Di Garbo V, Abruzzese G, et al. Cross-over study on effects of Mediterranean diet in two randomly selected population samples. Nutr Res 2003; 23: 1329-39.
2. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-8.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
4. Kondo K, Matsumoto A, Kurata H, et al. Inhibition of oxidation of low-density lipoprotein with red wine. (letter) Lancet 1994; 344: 1152.
5. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993; 88: 2771-9.
6. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-7. (Pubitemid 23054518)
7. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
8. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-11. (Pubitemid 23314801)
9. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-19.
10. Gebbia N, Bavaresco L, Fregoni M, et al. Contenuto di un nuovo stilbene (piceatannolo) in alcuni vini della Sicilia. Vignevini 2003; 30: 87-94.
11. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239: 70-6.
12. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 1998; 352: 1882-5.
13. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999; 100: 944-50.
14. Gaziano JM, Hennekens CH, Godfried SL, et al. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol 1999; 83: 52-7.
15. Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60.
16. Lacko AG, Barter P, Ehnholm C, van Tol A. International symposium on basic aspects of HDL, metabolism and disease prevention. J Lipid Res 2000; 41: 1695-9.
17. De Oliveira e Silva ER, Foster D, McGee Harper M, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins AI and AII. Circulation 2000; 102: 2347-52.
18. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J 1998; 19 (Suppl A): A2-A11. (Pubitemid 28112471)
19. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
20. Mennen LI, Balkau B, Vol S, Caces E, Eschwege E. Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999; 19: 887-92.
21. Numminen H, Syrjala M, Benthin G, Kaste M, Hillbom M. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke 2000; 31: 1269-73.
22. Pignatelli P, Lenti L, Pulcinelli FM, et al. Red and white wine differently affect collagen-induced platelet aggregation. Pathophysiol Haemost Thromb 2002; 32: 356-8. (Pubitemid 37490571)
23. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-33.
24. Cartron E, Fouret G, Carbonneau MA, et al. Red-wine beneficial long-term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine - description of two O-methylated derivatives of gallic acid in humans. Free Radic Res 2003; 37: 1021-35. (Pubitemid 37221034)
25. Di Garbo V, Bono M, Di Raimondo D, De Simone R, Raneli G, Avellone G. Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response. Eur J Clin Pharmacol 2000; 56: 277-84. (Pubitemid 30462923)
26. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7. (Pubitemid 32217685)
27. Sierksma A, van der Gaag MS, Kluft C, Hendriks HF. Moderate alcohol consumption reduces plama C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention study. Eur J Clin Nutr 2002; 56: 1130-6. (Pubitemid 35414800)
28. Goldfinger TM. Beyond the French paradox: the impact of moderate beverage alcohol and wine consumption in the prevention of cardiovascular disease. Cardiol Clin 2003; 21: 449-57.
29. de Lorgeril M, Salen P, Paillard F, Laporte F, Boucher F, de Leiris J. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res 2002; 54: 503-15. (Pubitemid 34595409)
30. Mezzano D, Leighton F, Martinez C, et al. Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr 2001; 55: 444-51.